Inositol as a treatment for psychiatric disorders: a scientific evaluation of its clinical effectiveness

Townsend Letter for Doctors and Patients, Oct, 2004 by Gina L. Nick

4. Levine, J. et al. 1995. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 152(5): 792-794.

5. Benjamin, J. et al. 1995a. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 152(7): 1084-1086.

6. Benjamin, J. et al. 1995b. Inositol treatment in psychiatry. Psychopharmacol Bull 31(1): 167-175.

7. Gelber et al. 2001. Effect of inositol on bulimia nervosa and binge eating. Int J Eat Disord. 29(3):345-8.

8. Palatnik, A. et al., 2001. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol 21(3): 335-339.

9. Fux, M. et al. 1996. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 153(9): 1219-1221.

10. Levine, J. et al. 1999. Combination of inositol and serotonin reuptake inhibitors in the treatment of depression. Biol Psychiatry 45(3): 270-273.

11. Chengappa et al. 2000. Inositol as an add-on treatment for bipolar depression. Bipolar Disord. 2(1):47-55.

12. Rahman, S. and R. S. Neuman. 1993. Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization. Brain Res 631(2): 349-351.

13. Greist, J. H. et al. 1995. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 52(1): 53-60.

14. Hefez, A. et al. 1987. Long-term effects of extreme situational stress on sleep and dreaming. Am J Psychiatry 144(3): 344-347.

15. Friedman CA, et al. 2000. Relationship between serum inositol concentration and development of retinopathy of prematurity: a prospective study. J Pediatr Ophthalmol Strabismus Mar-Apr;37(2): 79-86.

16. Greene, N. D. and A. J. Copp. 1997. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 3(1): 60-66.

17. Reece, E. A. et al. 1997. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol 176(3): 536-539.

18. Khandelwal, M. et al. 1998. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Teratology 57(2): 79-84.

19. Colodny, L. and R. L. Hoffman. 1998. Inositol--clinical applications for exogenous use. Altern Med Rev 3(6): 432-447.

20. Gill, D. L. et al. 1989. Calcium signalling mechanisms in endoplasmic reticulum activated by inositol 1,4,5-trisphosphate and GTP. Cell Calcium 10(5):363-374.

21. Graf, E. and J. W. Eaton. 1993. Suppression of colonic cancer by dietary phytic acid. Nutr Cancer 19(1): 11-19.

22. Graf, E. et al. 1987. Phytic acid. A natural antioxidant. J Biol Chem 262(24): 11647-1150.

23. Zhou, J. R. and J. W. Erdman. 1995. Phytic acid in health and disease. Crit Rev Food Sci Nutr 35(6): 495-508.

24. Carey et al. 2004. Single photon emission computed tomography (SPECT) in obsessive-compulsive disorder before and after treatment with inositol. Metab Brain Dis. 19(1-2):125-34.

25. Brink CB et al. 2004. Effects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells. Metab Brain Dis. 19(1-2):51-70.